# Paul S. Mischel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-s-mischel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,532 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 110 |
| i10-index | 264 |
| Last Known Institution | Stanford Medicine |
| OpenAlex ID | https://openalex.org/A5042065032 |
| ORCID iD | https://orcid.org/0000-0002-4560-2211 |
| Works | 615 |

## Researcher papers

- [Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma](https://scholariq.org/papers/antitumor-activity-of-rapamycin-in-a-phase-i-trial-for-patients-with-recurrent/)
- [Metabolic state of glioma stem cells and nontumorigenic cells](https://scholariq.org/papers/metabolic-state-of-glioma-stem-cells-and-nontumorigenic-cells/)
- [Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-plus-temozolomide-during-and-after-radiation/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)
- [Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.](https://scholariq.org/papers/imaging-proliferation-in-brain-tumors-with-18f-flt-pet-comparison-with-18f-fdg/)
- [Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies](https://scholariq.org/papers/somatic-mutations-of-the-parkinson-s-disease-associated-gene-park2-in/)
- [Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain](https://scholariq.org/papers/epidermal-growth-factor-receptor-activation-in-glioblastoma-through-novel/)
- [Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors](https://scholariq.org/papers/differential-sensitivity-of-glioma-versus-lung-cancer-specific-egfr-mutations-to/)
- [Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer](https://scholariq.org/papers/targeting-srebp-1-driven-lipid-metabolism-to-treat-cancer/)
- [Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment](https://scholariq.org/papers/recurrent-glioblastoma-multiforme-adc-histogram-analysis-predicts-response-to/)
- [MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy](https://scholariq.org/papers/mri-in-patients-with-high-grade-gliomas-treated-with-bevacizumab-and/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

## Researcher university

- [Stanford Medicine](https://scholariq.org/institutions/stanford-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.